OTC Regulation Ripple Effect
Over-the-counter (OTC) derivatives emerged from the financial crisis with a tarnished reputation. Derivatives came to embody the highly leveraged risk-spreading of the years leading up to the 2008 market downturn, so it’s no surprise that regulators on both sides of the Atlantic are pushing for OTC derivatives to be shunted onto more stringently regulated public trading platforms.
The argument goes that by improving the availability of information, enhanced transparency will improve the price
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: https://subscriptions.waterstechnology.com/subscribe
You are currently unable to print this content. Please contact info@waterstechnology.com to find out more.
You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@waterstechnology.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@waterstechnology.com
More on Regulation
Risk managers question US reach of Dora third-party list
Some EU subsidiaries included, but regulator control over cloud providers could still be limited.
Where have four years of Cusip legal drama gone?
The IMD Wrap: The antitrust case against Cusip Global Services has been a long, winding road. Reb recaps what you might have missed.
2026 will be the year agent armies awaken
Waters Wrap: Several AI experts have recently said that the next 12 months will see significant progress for agentic AI. Are capital markets firms ready for this shift from generative AI to agents?
Despite regulatory thaw in US, major questions remain globally for 2026
From crypto and tokenization to the CAT to consolidated tapes to T+1’s advancement, the regulatory space will be front and center in the New Year.
Will overnight trading in equity markets expand next year? It’s complicated.
The potential for expanded overnight trading in US equity markets sparked debate this year, whether people liked it or not.
Waters Wavelength Ep. 342: LexisNexis Risk Solutions’ Sophie Lagouanelle
This week, Sophie Lagouanelle, chief product officer for financial crime compliance at LNRS, joins the podcast to discuss trends in the space moving into 2026.
Citadel Securities, BlackRock, Nasdaq mull tokenized equities’ impact on regulations
An SEC panel of broker-dealers, market-makers and crypto specialists debated the ramifications of a future with tokenized equities.
FIX Trading Community recommends data practices for European CTs
The industry association has published practices and workflows using FIX messaging standards for the upcoming EU consolidated tapes.
